Using convalescent plasma, Griffith University researchers have identified how it may be possible to make a future vaccine that will provide protection against all major strains of COVID-19
A vaccine is key to the COVID-19 global response strategy. However, it is not yet clear how any COVID-19 vaccine...
A next-generation COVID-19 mucosal vaccine is set to be a gamechanger not only when delivering the vaccine itself, but also for people who are needle-phobic.
Professor Paul Clarke will join the University as the inaugural Executive Director of the new Institute for Biomedicine and Glycomics.
Is man flu real? Is there a valid biological reason behind men’s symptoms or are men just malingering? And how does man flu differ from flu? Professor Thea van de Martel explains.
In a world-first discovery, Griffith University researchers have discovered faulty cell function in veterans suffering from Gulf War Illness (GWI),...
Griffith University has reached the milestone achievement of raising $100 million of its $125 million target as part of The Campaign to Create a Brighter Future for All.
Native Charge Detection Mass Spectrometry will enable cross-collaboration research to develop life-changing therapies, vaccines and diagnostics.
Griffith researchers among 19 scientists share in $5.56 million of funding.
In a significant breakthrough, researchers from the Swiss Tropical and Public Health Institute (Swiss TPH) and Griffith University’s Institute for...
